How Antibiotics Work, and Why Resistance Is Rising

Antibiotics work by attacking structures and processes that bacteria need to survive and multiply, such as their cell walls, their protein-building machinery, or the enzymes that copy their DNA, either killing the bacteria outright or stopping them from reproducing long enough for the immune system to clear the infection. They exploit the fact that bacterial cells are built differently from human cells. That is also why they are useless against viruses, and why using them carelessly is steadily eroding their power.

This article explains the mechanism in plain terms and why resistance is on the rise. It is general information about how a class of medicines works, not medical advice; decisions about treatment should always be made with a qualified clinician.

What is an antibiotic?

An antibiotic is a medicine that fights infections caused by bacteria, a group of single-celled microorganisms. The word is often used loosely, but strictly it refers to drugs active against bacteria, not against viruses, fungi or parasites, which need antivirals, antifungals and antiparasitics respectively.

The modern era began in 1928, when the Scottish scientist Alexander Fleming noticed that a mould, Penicillium, killed bacteria growing on a culture plate. The compound he identified, penicillin, was developed into a usable drug in the 1940s and transformed infections that had routinely been fatal into treatable conditions.

How do antibiotics actually kill or stop bacteria?

Antibiotics work by hitting targets that bacteria depend on but that human cells either lack or build differently. There are three main points of attack: the cell wall that surrounds a bacterium, the machinery that copies its DNA and RNA, and the ribosomes that assemble its proteins.

Beta-lactam antibiotics, a family that includes penicillin and amoxicillin, block the construction of the bacterial cell wall. Without an intact wall the cell cannot hold its shape, absorbs too much water and bursts. Human cells have no such wall, so these drugs can hit bacteria hard while largely leaving the body alone.

Other classes take different routes. Fluoroquinolones such as ciprofloxacin jam the enzymes bacteria use to copy their DNA, so the genetic material breaks apart when the cell tries to divide. Macrolides and tetracyclines bind to bacterial ribosomes and stop protein production. The common thread is that each drug sabotages a process essential to bacterial life.

What is the difference between bactericidal and bacteriostatic drugs?

Bactericidal antibiotics kill bacteria directly, whereas bacteriostatic antibiotics stop them from multiplying without immediately killing them. With a bacteriostatic drug the population stops growing, and the patient’s own immune system then mops up the paused bacteria.

Neither type is automatically better. The right choice depends on the bacterium, the site of the infection and the patient’s immune status, which is one reason self-treating with leftover pills is a poor idea.

What are broad-spectrum and narrow-spectrum antibiotics?

Antibiotics also differ in how many kinds of bacteria they affect. Broad-spectrum drugs act against a wide range of bacteria at once, which is useful when the exact culprit is not yet known, whereas narrow-spectrum drugs target only a few types.

The convenience of broad-spectrum drugs comes at a cost. Because they hit many species, they disturb more of the body’s helpful bacteria and apply selective pressure across a broad front, which can hasten resistance. Clinicians therefore often start broad when an infection is serious and the cause uncertain, then switch to a narrower drug once laboratory tests identify the specific bacterium, matching the treatment as closely as possible to the problem.

Why don’t antibiotics work on viruses?

Antibiotics do not work on viruses because viruses are not cells and lack the structures the drugs attack. A virus has no cell wall to disrupt, no ribosomes of its own to jam and no independent metabolism; it hijacks a host’s cells to reproduce. With nothing for the antibiotic to target, the drug does nothing to the virus.

This is why colds, most sore throats, flu and COVID-19 do not respond to antibiotics. Viral infections are instead managed with rest, supportive care, or in some cases antiviral drugs, which are designed to interrupt specific steps in a particular virus’s life cycle. The table below sets out the contrast.

Feature	Antibiotics	Antivirals
Target	Bacteria	Viruses
How they act	Disrupt cell walls, DNA copying or protein-making	Block specific steps a virus uses to replicate
Breadth	Some are broad-spectrum, hitting many bacteria	Usually narrow, often one virus family
Example illnesses	Strep throat, urinary tract infection, some pneumonias	Influenza, HIV, hepatitis C, COVID-19

What is antibiotic resistance, and how does it develop?

Antibiotic resistance is the ability of bacteria to survive exposure to a drug that would normally kill them or stop them growing. It is an example of evolution in fast motion: within a large bacterial population, a few cells may carry traits that let them withstand the drug, and when the antibiotic wipes out the susceptible majority, the survivors multiply.

Bacteria acquire resistance in two broad ways. Random mutations in their DNA can change the target a drug binds to, switch on pumps that eject the drug, or produce enzymes that chop the drug apart. Just as important, bacteria can pass resistance genes to one another directly through a process called horizontal gene transfer, so a trait that arises in one species can spread to others.

Resistance is a property of the bacteria, not of the patient. A person does not build up a tolerance to antibiotics; the microbes evolve to evade them.

Why is resistance rising?

Resistance rises fastest where antibiotics are used most, because every use applies selective pressure that favours resistant survivors. Prescribing the drugs for viral illnesses they cannot treat, not completing appropriate courses, and using them heavily in agriculture all add to that pressure.

The World Health Organization describes antibiotic resistance as one of the biggest threats to global health, because it can make once-routine infections and surgeries dangerous again. When common drugs fail, clinicians must reach for older, more toxic or more expensive alternatives, and for some infections the options are running low.

Compounding the problem, the pipeline of genuinely new antibiotics has thinned. Developing a new drug is slow and costly, and because any new antibiotic is ideally held in reserve to slow resistance, it may sell modestly, which weakens the commercial incentive to invent more. The result is a race in which bacteria are adapting faster than replacements arrive.

How can resistance be slowed?

Resistance can be slowed by using antibiotics only when they are genuinely needed and exactly as directed. That means not pressing for them for coughs and colds, not sharing or saving pills, and following a prescriber’s instructions on dose and duration.

Prevention also reduces the need for antibiotics in the first place: hand-washing, vaccination and safe food handling all cut the number of infections that arise. Because the trend is driven by collective behaviour, individual choices genuinely add up.

The bottom line

Antibiotics are precision tools that exploit the differences between bacterial and human cells, and they revolutionised medicine within living memory. But they act only on bacteria, they lose ground every time they are misused, and resistance now spreads faster than new drugs are discovered. Treating them as a finite, shared resource, and leaving prescribing decisions to clinicians, is what keeps them working.

Sources

• CDC — About Antibiotic Use
• World Health Organization — Antibiotic resistance
• Mayo Clinic — Bacterial vs. viral infections
• StatPearls (NCBI Bookshelf) — Antibiotic Resistance

Related from Health